Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a Particulated Human Acellular Dermal Matrix Skin Booster: A Randomized, Split-Face, Double-blinded, Prospective Clinical Trial

NCT07155278 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT07155278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a Particulated Human Acellular Dermal Matrix Skin Booster: A Randomized, Split-Face, Double-blinded, Prospective Clinical Trial
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Completed
Start date
November 21, 2024
Completion date
May 7, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

photoaged facial skin, rhytides, skin lifting and tightening, skin texture irregularities